rapid HBc/HIV/HCV antibody test
Accurate, rapid simultaneous detection of antibodies to HIV-1/2, Hepatitis B core antigen (HBc), and Hepatitis C virus (HCV).
One Test – Three Answers
The Multiplo® Rapid HBc/HIV/HCV Antibody Test enables simultaneous detection of Human Immunodeficiency Virus Type 1 and Type 2 (anti-HIV-1/2), total antibodies (IgG and IgM) to Hepatitis B core antigen (anti-HBc total), and antibodies to Hepatitis C virus (anti-HCV), using MedMira’s Rapid Vertical Flow (RVF) Technology™. Its simple and proven three-step procedure delivers fast, reliable results.
-
Immediate results
No waiting time, results do not vanish.
-
Reliable accuracy
Achieves high testing performance across multiple specimen matrices.
-
Multiplex testing
Multiple diseases tested on a single cartridge using one blood sample.
-
No equipment or refrigeration required
Stores at room temperature (2–30 °C / 35–86 °F) with an 18-month shelf life.
-
Easy to use and interpret
Simple procedure with instant, easy-to-read results, no special training required.
-
Ideal for any setting
Works with serum, plasma, and whole blood (venipuncture or fingerstick).
in three simple Steps
Testing doesn’t have to be complicated. Our intuitive three-step process ensures instant, consistent results with minimal effort.
Pour buffer onto the InstantGold™ cap.
Place the InstantGold™ cap on the cartridge.
Pour lysed blood specimen into the test cartridge.
For a detailed walkthrough, watch video (Youtube, 3:16 min)
Place InstantGold™ cap on the test & add buffer.
Apply specimen to the centre of the test membrane.
Apply buffer to the test center.
For a detailed walkthrough, watch video (Youtube, 2:36 min)
Explore your options with us
This product is available for international applications outside North America and the EU. For information regarding Multiplo® Rapid HBc/HIV/HCV Antibody Test, including availability, ordering procedures, and technical documentation, please contact our team.
Our test tailored to your needs
The Multiplo® Rapid HBc/HIV/HCV Antibody Test is trusted worldwide for both point-of-care and laboratory settings. Working with regional distribution partners, we provide broad access to three formats designed for different testing environments.
This format includes a test tray in each pouch and is ideally suited to testing at the point of patient care, settings such as mobile clinics requiring a portable and all-in-one testing solution.
- Cat. No. 815311004551
- Qty. 20 tests per box
- Downloads. Package Insert – EN
The LAB+ format is designed for laboratory use, offering maximum flexibility for testing serum, plasma, and venipuncture whole blood with reliable and consistent results.
- Cat. No. 815311004575
- Qty. 50 tests per box
- Downloads. Package Insert – EN
The LAB S/P format is designed for laboratory use, ideally suited for serum and plasma specimens and batch testing, ensuring efficient processing and dependable performance.
- Cat. No. 815311004582
- Qty. 50 tests per box
- Downloads. Package Insert – EN
Related Products
Designed for use across POC settings, laboratories, academic institutions, and research environments.
Designed for use across POC settings, laboratories, academic institutions, and research environments.
Miriad is intended for laboratory, academic, and research use only, and is not for use in diagnostic procedures.
Learn more about our upcoming technology and products advancing through our development pipeline.
Frequently Asked Questions
To learn more about Multiplo® Rapid HBc/HIV/HCV Antibody Test, please contact us.
The Multiplo® Rapid HBc/HIV/HCV Antibody Test demonstrates 96.2% sensitivity and 100% specificity for HBc antibodies, 99.8% sensitivity and 99.7% specificity for HIV antibodies, and 99.1% sensitivity with 99.7% specificity for HCV antibodies.
Rapid tests provide valuable advantages across a range of environments, from point-of-care settings to research and laboratory workflows. They deliver results within minutes without relying on extensive infrastructure, specialized instruments, or highly trained personnel, which helps reduce costs and streamline testing processes. Modern rapid assays often demonstrate performance comparable to laboratory methods, making them a practical option for decentralized screening, high-throughput research studies, emergency situations, and programs that require immediate decision-making or broad accessibility.
Contact Us
Yes. Our Multiplo® product line offers testing for several diseases within a single test cartridge and includes assays such as the Multiplo® Rapid TP/HIV Test, which holds regulatory approvals in Canada (home country approval) and is used in international markets where applicable. In addition, our Miriad® product line – available for research use only – provides further testing options, including assays capable of detecting HBc, HIV, and HCV.
HBV, HIV, and HCV are bloodborne infections that often occur in overlapping risk settings, particularly where exposure to contaminated blood or shared injection equipment is possible. Streamlined testing for these markers enables efficient screening, especially in environments with limited laboratory capacity or where consolidated workflows are preferred. A combined test reduces the need for multiple separate assays by detecting antibodies to all three viruses in a single procedure, helping improve efficiency and simplify sample management. The Multiplo® Rapid HBc/HIV/HCV Antibody Test supports effective testing through its simple and proven three-step process, delivering reliable results with minimal hands-on time.
